About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 4NCT00592969

Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes

This trial is conducted in South America. The aim of this trial is to evaluate the efficacy of metformin plus biphasic insulin aspart or insulin NPH on blood glucose control in subjects with type 2 di...

Lead sponsor: Novo Nordisk A/S•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Novo Nordisk A/S

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Type 2 diabetes
•Currently treated with insulin NPH or are insulin-naive
•Body mass index (BMI) below 35.0 kg/m2
•HbA1c between 7.5-11.0%

Exclusion Criteria

•Participation in any other clinical trial involving investigational products within the last 3 months
•History of drug or alcohol dependence
•Known impaired hepatic function
•Known or suspected allergy to human insulin NPH, insulin aspart or any component of the composition

Related studies

Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on the Prevention of Type 2 Diabetes

NCT07659535 · Type 2 Diabetes

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD)

NCT07102043 · Cystic Fibrosis Related Diabetes

RECRUITINGPhase 1

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

NCT07590193 · Diabetes Mellitus, Type 2

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 24, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment164

Start dateDec 2003

Last updatedFeb 24, 2017

Condition

Diabetes Diabetes Mellitus, Type 2

Locations shown

Novo Nordisk Investigational Site

Mariano Acosta S/n

Novo Nordisk Investigational Site

Santa Efigênia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 24, 2017Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions